| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Department of Human Physiology and Centre for Neuroscience and 2 Department of Medical Biochemistry, Flinders University, Adelaide, South Australia, Australia
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS AND METHODS |
|---|
|
|
|---|
-dihydrotestosterone (DHT; 0.1 nmol/L) as described previously (8)
.
Total RNA isolation and reverse transcription were performed using the RNeasy and Ominiscript RT kits (Qiagen, Valencia, CA) following the manufacturers instructions. The PCR primers (synthesized by Geneworks, Adelaide, Australia) used in the study were TRPM8 (NM_024080; base: 457 to 1138): 5'-GAAAACACCCAACCTGGTCATTTC-3' (sense): 5'-CACCGTGCGGGGTAAAAAGCG-3' (antisense); ANKTM1 (NM_007332; base: 1001 to 1412): 5'-TTCATTTTGCTGCCACCCAG-3' (sense), 5'-CCATCGTTGTCTTCATCCATTACC-3' (antisense); TRPV1 (AY131289; base: 1755 to 2098): 5'-CGTCTTCTTGTTCGGGTTTTCC-3' (sense), 5'- GCTTCCAGATGTTCTTGCTCTCC-3' (antisense); and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; BC023632; base: 527 to 889): 5'-TTGGTATCGTGGAAGGACTC-3' (sense), 5'-TGCTGTTGAAGTCAGAGGAGAC-3' (antisense). PCR was conducted (7)
using HotStart Taq Master Mix kit (Qiagen) for 20 cycles (GAPDH) and 30 cycles (TRP channels). Initial denaturation was 15 minutes at 95°C and 1 minute at 94°C, followed by a 30-second annealing step at 55°C, 57°C, 55°C, and 56°C for TRPM8, ANKTM1, TRPV1, and GAPDH, respectively, 1-minute elongation at 72°C, and a final elongation of 10 minutes at 72°C. PCR products were analyzed by gel-electrophoresis and DNA sequencing (7)
. To determine the relative abundance of TRPM8 mRNA, the density of each TRPM8 band (measured using
Imager software; Bio-Rad, Hercules, CA) was compared with that of the respective GAPDH band after background subtraction, and the results are expressed in arbitrary ratio units (aru).
Small Interference RNA Targeted against TRPM8.
Small interference RNA (siRNA) targeted against TRPM8 was designed using siRNA Target Finder (Ambion, Inc., Austin, TX), according to the mRNA sequence of human TRPM8 (NM_024088). The TRPM8 siRNA sequence was 5'-AGAAAUUCUCGAAUGUUCUUU-3' (sense) and 3'-UUUCUUUAAGAGCUUACAAGA-5' (antisense). The sequence of a negative control siRNA was 5'-UUCUAAUAGGCAUAUUAUCUU-3' (sense) and 3'-UUAUGAUUAUCCGUAUAAUAG-5' (antisense). The siRNAs were produced using the Silence siRNA Construction Kit (Ambion) following the manufacturers instructions. Transfection of LNCaP cells with siRNA (20 nmol/L) was conducted by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) following the manufacturers instructions. The estimated percentage transfection was >90%.
Identification of Putative Androgen-Response Element Motifs.
The 5 kb of genomic sequence upstream of human TRPM8 mRNA sequence and all of its intron sequences (National Center for Biotechnology Information, Bethesda, MD) were used to search for sequences similar to the consensus androgen-response element motif AGAACAnnnTGTTCT (TRANSFAC, Wolfenbüttel, Germany). Scoring was based on the number of nucleotides in the query sequence that matched the consensus sequence using MacVector 7.1 (Accelrys, San Diego, CA). Sequence matches with at least 9 identities of the 12 consensus nucleotides (75%) were taken as showing similarity. All of the putative androgen-response element motifs were aligned using MacVector 7.1 ClustalW (Accelrys; ref. 9
).
Immunocytochemistry.
Cells were fixed with 4% (w/v) paraformaldehyde, blocked with 20% (v/v) FCS, then incubated with anti-TRPM8 antibody [Abcam, Cambridge, United Kingdom; 1:500 dilution, which detects a single Mr 130,000 band corresponding to the predicted molecular weight of TRPM8 gene product (Mr 128,000) in COS-7 cells heterologously expressing TRPM8; ref. 2
] with or without 1:40 dilution of antiCD-9 antibody (ref. 10
; Dr. Leonie Ashman, University of Adelaide, Australia) at 4°C overnight, and then with antirabbit IgG secondary antibody conjugated with FITC (1:500 dilution) and antimouse IgG secondary antibody conjugated with Cy3 (1:500 dilution; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) for 2 hours at room temperature. DiOC6 (Sigma, St. Louis, MO; 1 mmol/L) was used to stain the ER (1 minute at room temperature). Cells were viewed using an Olympus AX70 microscope (Melville, NY) equipped with epifluorescence or attached to a Bio-Rad 1024 scanning confocal system equipped with an argon ion (488 nm) and a helium neon (543 nm) for excitation of FITC or DiOC6, and Cy3, respectively. Confocal images were taken in the equatorial plane. For quantitation, immunofluorescence intensity [arbitrary pixel units (apu)] of each cell was measured using NIH image 1.62.
Measurement of the [Ca2+]cyt.
Intracellular Ca2+ imaging using Fura-2 was conducted as described previously (8)
. Temperature was controlled by a temperature controller (Cell Microcontrol System, Norfolk, VA) and monitored by a thermistor placed within 160 µm of the field of view. Menthol, thapsigargin, and capsazepine (Sigma) were each applied by superfusion. The rate of Ca2+ inflow was determined by measuring the initial slope of the extracellular Ca2+ (Ca2+E)-induced increase in fluorescence ratio [fluorescence ratio unit (fru)/s; ref. 8
]. The amount of Ca2+ released from intracellular stores was estimated by calculating the area under the Ca2+ release (fru x s) curve (11)
. In each case, the difference between the maximal fluorescence ratio value induced by menthol or thapsigargin and the minimum fluorescence ratio value after [Ca2+]cyt had decreased and reached a steady-state value was measured and multiplied by the width of the Ca2+ release peak at half height.
Cell Viability and Apoptosis.
Cell viability was measured using the MTT (Sigma) test, and apoptotic cells were detected using ethidium bromide (Sigma; ref. 8
).
Data Analysis.
Results are expressed as mean ± SE. Statistical analysis was performed using Students t test for unpaired samples. A value of P < 0.05 was taken as significant.
| RESULTS |
|---|
|
|
|---|
|
Intracellular Localization of TRPM8 in an Androgen-Sensitive Cell Line.
Using confocal microscopy, the majority of TRPM8 protein was found associated with a reticular structure outside the nucleus (Fig. 2A and D)
. Cells were costained with DiOC6 to define the location of the ER (Fig. 2B)
. An antibody against CD-9, located at the PM in LNCaP cells and in a number of other cell types (8
, 10)
, was used as a PM marker. Images of LNCaP cells treated with the antiCD-9 antibody revealed a clear location of the CD-9 protein at the PM (Fig. 2E)
. Overlay of the TRPM8 and DiOC6 images and the TRPM8 and CD-9 images showed that based on fluorescence intensity, approximately one-half the intracellular TRPM8 protein is colocated with DiOC6 (in the ER; Fig. 2C
) and approximately one-half is colocated with CD-9 in a band that occupies
30% to 50% of the PM (indicated by the arrows in Fig. 2F
).
|
|
95% of the intracellular Ca2+ stores (13)
. Thapsigargin evoked a transient increase in [Ca2+]cyt (Fig. 3D)
However, when menthol (500 µmol/L) was added before thapsigargin, an increase in [Ca2+]cyt (1.8 ± 0.5 fru x s; n = 3) was observed, followed by another increase with higher magnitude (12.5 ± 1.5 fru x s; n = 3) induced by thapsigargin (Fig. 3E)
.
Menthol-Sensitive Ca2+ Influx and Ca2+ Store Release Are Regulated by Androgen in an Androgen-Sensitive Cell Line.
To test whether androgen regulates TRPM8-mediated Ca2+ inflow and Ca2+ release, cells were grown in RPMI plus charcoal-stripped FCS for 4 days, and [Ca2+]cyt then was measured in the presence of 2 mmol/L Ca2+E. The initial rate of increase in [Ca2+]cyt in response to menthol() (100 µmol/L) in cells grown in RPMI plus FCS (normal culture medium) was 41.0 ± 6.7 x 105 fru x s (n = 3). This was reduced to 9.5 ± 1.5 x 105 fru/s (n = 3; P < 0.001) in cells grown in RPMI plus charcoal-stripped FCS but was restored to 32.8 ± 5.5 x 105 fru/s (n = 3) for cells grown in the presence of DHT. The amount of Ca2+ released by menthol() (500 µmol/L) in cells incubated in the absence of added Ca2+E was 1.6 ± 0.3 fru x s (n = 3) in cells grown in RPMI plus FCS. This was decreased to 0.11 ± 0.1 fru x s (P < 0.001; n = 3) for cells grown in RPMI plus charcoal-stripped FCS. No significant decrease was observed in thapsigargin-induced Ca2+ release measured in the absence of added Ca2+E in cells grown in RPMI plus charcoal-stripped FCS (10.8 ± 1.2 fru x s; n = 3) when compared with cells grown in RPMI plus FCS (13 ± 1.8 fru x s; n = 3).
Expression of TRPM8 in an Androgen-Insensitive Cell Line.
The expression of TRPM8 in the PC-3 androgen-insensitive cell line also was investigated. Immunocytochemistry using the TRPM8 antibody showed that TRPM8 was detected in PC-3 cells (Fig. 4
, compare B with A). The other interesting finding was that TRPM8 immunofluorescence was clearly seen on plasma membrane in
20% of all of the PC-3 cells examined (Fig. 4E)
. Those cells that exhibited TRPM8 immunofluorescence at the plasma membrane usually were large and exhibited polymorphism.
|
Evidence for functional expression of TRPM8 in PC-3 cells was obtained using Ca2+ imaging and menthol. For PC-3 cells incubated in the presence of 2 mmol/L Ca2+E, a high concentration of menthol (1000 µmol/L) induced a small increase in [Ca2+]cyt (Fig. 4F)
. These results indicate that TRPM8 is expressed at a low level in PC-3 cells, but its expression in these cells is not regulated by androgen.
Capsazepine Reduces the Survival of Androgen-Sensitive Cells by Induction of Apoptosis.
To test whether the androgen-regulated TRPM8 Ca2+-permeable channel is coupled with Ca2+ and other signaling pathways involved in cell survival (14
, 15)
, LNCaP cells were incubated with capsazepine for 3 days, and nuclear morphology and cell viability then were examined. Cells grown in RPMI plus FCS with 10 µmol/L capsazepine exhibited nuclear condensation and fragmentation (Fig. 5
, compare C with A), whereas cells grown in RPMI plus charcoal-stripped FCS (to down-regulate expression of TRPM8) with 10 µmol/L capsazepine did not (Fig. 5
, compare D with B). The percentage of viable cells, assessed using the MTT test, in cultures of capsazepine-treated cells was significantly decreased compared with that of cells grown under normal conditions (Fig. 5E)
. In contrast, when cells were grown in RPMI plus charcoal-stripped FCS, those treated with 1 and 10 µmol/L capsazepine retained viability, whereas those incubated with 50 µmol/L capsazepine exhibited decreased viability (Fig. 5E)
.
|
50% compared with the effects of negative control siRNA, TRPM8 antisense RNA, and nontransfected cells (Fig. 6AC)
|
|
| DISCUSSION |
|---|
|
|
|---|
Whereas cooling and menthol induced a small increase in [Ca2+]cyt in LNCaP cells incubated in the absence of Ca2+E, these increases in [Ca2+]cyt were much smaller than those observed in cells incubated in the presence of Ca2+E. Moreover, a much higher concentration of menthol was required to cause a detectable increase in [Ca2+]cyt in the absence of Ca2+E, and the effect of menthol was considerably smaller than that of thapsigargin. These results indicate that although cooling and menthol induce the release of some Ca2+ from intracellular stores, the predominant effect is the activation of Ca2+ inflow. It is possible that Ca2+ inflow through store-operated Ca2+channels (activated by the decrease in [Ca2+] in the ER induced by the effect of cooling or menthol on TRPM8 in the ER) makes some contribution to the observed Ca2+ inflow initiated by cooling and menthol. The action of cooling and menthol in stimulating Ca2+ fluxes across the PM and the ER membrane is consistent with the intracellular location of the TRPM8 protein at these two sites.
The activation by menthol of TRPM8 located at intracellular sites requires that menthol can move into the cytoplasmic space. Several studies provide indirect evidence that cell membranes are permeable to menthol. Thus, it has been shown that menthol increases the transdermal and transbuccal absorption of drugs by affecting intracellular lipids and proteins (20 , 21) and inhibits arylamine N-acetyltransferase activity in human liver tumor cells (22) . These results, as well as the knowledge that menthol is lipid soluble (20 , 21) , suggest that it is likely menthol can diffuse from the extracellular space to intracellular TRPM8 locations.
Our results clearly show that androgen increases and the absence of androgen decreases TRPM8 protein expression and Ca2+ flow across the PM and ER mediated by TRPM8 in an androgen-responsive cell line. We looked for putative androgen response elements based on the consensus androgen-response element AGAACAnnnTGTTCT (9)
in the regulatory region of the human TRPM8 gene (2)
. One putative androgen-response element was identified in the 5' flank region of TRPM8 gene that is close to the transcription start site (242; Fig. 8
). Eleven putative androgen-response elements were identified in introns of the TRPM8 gene. In particular, in introns 3 and 22, two androgen-response elements with high homology with the TRANSFAC consensus androgen-response element motif (11 of 12, 92%, of nucleotides were identical) were detected (Fig. 8)
. These putative androgen-response elements may confer the inducibility of TRPM8 gene expression by androgen at transcription level in prostate cells.
|
Capsazepine, at concentrations in the range that are known to inhibit the activation of heterologously expressed TRPM8 (18)
, and suppression of TRPM8 expression with siRNA each increased the number of androgen-responsive LNCaP cells undergoing apoptosis and decreased cell viability. These observations indicate that the normal function of TRPM8 is required for LNCaP cell survival. The concentration of capsazepine that reduced the percentage of viable cells by
50% was
50 µmol/L. This is within the range of 20 µmol/L reported for the concentration of capsazepine that gives 50% inhibition of TRPM8 heterologously expressed in HEK-293 cells (18)
. Although an effect of capsazepine on TRPV1 can be excluded, as argued previously, the possibility that the capsazepine-induced decrease in cell viability is caused by the action of capsazepine on a protein(s) other than TRPM8 cannot be completely excluded (24)
. However, the observation that the effect of capsazepine in reducing cell viability is considerably decreased in cells incubated in RPMI plus charcoal-stripped FCS (androgen-deprived medium; in which expression of TRPM8 also is considerably decreased) provides additional evidence that the effect of capsazepine is via inhibition of the TRPM8 channel.
If TRPM8 is proposed to be necessary for cell survival and if TRPM8 expression is reduced in LNCaP cells incubated in RPMI plus charcoal-stripped FCS, it might be predicted that capsazepine would have a greater effect in reducing the percentage of viable cells when LNCaP cells are grown in RPMI plus charcoal-stripped FCS. However, this was not observed (Fig. 5E)
. This is likely because of differences in the culture medium and the effects of growth in RPMI plus charcoal-stripped FCS per se (23)
. Thus, the initial culture conditions (FCS compared with charcoal-stripped FCS) are different, as indicated by the observation that in the absence of capsazepine, the percentage of viable cells present in RPMI plus charcoal-stripped FCS is only 60% of that in RPMI plus FCS (normal medium).
Menthol decreased the percentage of viable cells and increased the number of cells undergoing apoptosis in LNCaP cells cultured in RPMI plus FCS (normal medium that contains 2 mmol/L Ca2+E). Because menthol was shown to cause a sustained increase in [Ca2+]cyt in LNCaP cells, it is likely that menthol-induced cell death is mediated at least in part by the sustained increase in [Ca2+]cyt. This likely represents a pathophysiologic action of TRPM8 (the channel would not normally be activated in a sustained manner) as compared with a normal role in cell survival as revealed by the experiments with capsazepine and TRPM8 siRNA.
Considering the normal physiologic function of TRPM8, it recently has been suggested that TRPM8 serves as a cold sensor in the prostate (25) . TRPM8 also may be involved in other functions such as the regulation of proliferation and/or apoptosis (and hence the control of cell number) and in ion and protein secretion in prostate epithelial cells. One interesting possibility comes from the recent observation that geraniol activates TRPM8 (18) . The PPi ester of geraniol is an intermediate in cholesterol synthesis (26) , and geraniol enhances cell proliferation in prostate epithelium (27) . Thus, it is possible that in prostate epithelial cells, TRPM8 is involved in the regulation of cell proliferation and responds to geraniol as an intracellular messenger.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Requests for reprints: Lei Zhang, Department of Human Physiology, School of Medicine, Faculty of Health Sciences, G.P.O. Box 2100, Adelaide, South Australia, 5001, Australia. Phone: 61-8-8204-8945; Fax: 61-8-8204-5768; E-mail: Lei.zhang{at}flinders.edu.au
Received 6/17/04. Revised 8/28/04. Accepted 9/ 8/04.
| REFERENCES |
|---|
|
|
|---|
from plasma. Clin Chem 1981;27:612-4.This article has been cited by other articles:
![]() |
C. S. Aung, W. Ye, G. Plowman, A. A. Peters, G. R. Monteith, and S. J. Roberts-Thomson Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells Carcinogenesis, November 1, 2009; 30(11): 1962 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Johnson, D. Melanaphy, A. Purse, S. A. Stokesberry, P. Dickson, and A. V. Zholos Transient receptor potential melastatin 8 channel involvement in the regulation of vascular tone Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1868 - H1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lazzeri, E. Costantini, and M. Porena Review: TRP family proteins in the lower urinary tract: translating basic science into new clinical prospective Therapeutic Advances in Urology, April 1, 2009; 1(1): 33 - 42. [Abstract] [PDF] |
||||
![]() |
A. S. Sabnis, M. Shadid, G. S. Yost, and C. A. Reilly Human Lung Epithelial Cells Express a Functional Cold-Sensing TRPM8 Variant Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamura, S. Ugawa, T. Ueda, A. Morita, and S. Shimada TRPM8 activation suppresses cellular viability in human melanoma Am J Physiol Cell Physiol, August 1, 2008; 295(2): C296 - C301. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. De Petrocellis, V. Vellani, A. Schiano-Moriello, P. Marini, P. C. Magherini, P. Orlando, and V. Di Marzo Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8 J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 1007 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Phelps and R. Gaudet The Role of the N Terminus and Transmembrane Domain of TRPM8 in Channel Localization and Tetramerization J. Biol. Chem., December 14, 2007; 282(50): 36474 - 36480. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. U. Bai, A. Kaseb, S. Tejwani, G. W. Divine, E. R. Barrack, M. Menon, A. B. Pardee, and G. P.-V. Reddy Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine PNAS, February 13, 2007; 104(7): 2343 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mahieu, G. Owsianik, L. Verbert, A. Janssens, H. De Smedt, B. Nilius, and T. Voets TRPM8-independent Menthol-induced Ca2+ Release from Endoplasmic Reticulum and Golgi J. Biol. Chem., February 2, 2007; 282(5): 3325 - 3336. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kiselyov, A. Soyombo, and S. Muallem TRPpathies J. Physiol., February 1, 2007; 578(3): 641 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. Abeele, A. Zholos, G. Bidaux, Y. Shuba, S. Thebault, B. Beck, M. Flourakis, Y. Panchin, R. Skryma, and N. Prevarskaya Ca2+-independent Phospholipase A2-dependent Gating of TRPM8 by Lysophospholipids J. Biol. Chem., December 29, 2006; 281(52): 40174 - 40182. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Derler, M. Hofbauer, H. Kahr, R. Fritsch, M. Muik, K. Kepplinger, M. E. Hack, S. Moritz, R. Schindl, K. Groschner, et al. Dynamic but not constitutive association of calmodulin with rat TRPV6 channels enables fine tuning of Ca2+-dependent inactivation J. Physiol., November 15, 2006; 577(1): 31 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang and G. J Barritt TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocr. Relat. Cancer, March 1, 2006; 13(1): 27 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Clapham, D. Julius, C. Montell, and G. Schultz International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels Pharmacol. Rev., December 1, 2005; 57(4): 427 - 450. [Full Text] [PDF] |
||||
![]() |
S. Thebault, L. Lemonnier, G. Bidaux, M. Flourakis, A. Bavencoffe, D. Gordienko, M. Roudbaraki, P. Delcourt, Y. Panchin, Y. Shuba, et al. Novel Role of Cold/Menthol-sensitive Transient Receptor Potential Melastatine Family Member 8 (TRPM8) in the Activation of Store-operated Channels in LNCaP Human Prostate Cancer Epithelial Cells J. Biol. Chem., November 25, 2005; 280(47): 39423 - 39435. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilius, T. Voets, and J. Peters TRP Channels in Disease Sci. Signal., August 2, 2005; 2005(295): re8 - re8. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nadif Kasri, G. Bultynck, J. B. Parys, G. Callewaert, L. Missiaen, and H. De Smedt Suramin and Disulfonated Stilbene Derivatives Stimulate the Ca2+-Induced Ca2+-Release Mechanism in A7r5 Cells Mol. Pharmacol., July 1, 2005; 68(1): 241 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Bidaux, M Roudbaraki, C Merle, A Crepin, P Delcourt, C Slomianny, S Thebault, J-L Bonnal, M Benahmed, F Cabon, et al. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement Endocr. Relat. Cancer, June 1, 2005; 12(2): 367 - 382. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |